FDA to review Inspire Medical's sleep apnea implant
Medtronic spin-out Inspire Medical Systems will next month undergo FDA advisory panel review for its implantable Inspire II Upper Airway Stimulator for treatment of obstructive sleep apnea.
Inspire Medical Systems is getting the FDA treatment, landing a date next month with the Anesthesiology & Respiratory Therapy Devices panel to undergo review of the company's implanted Inspire II Upper Airway Stimulator for treatment of obstructive sleep apnea.
The device is a permanent implant designed to stimulate nerves associated with the upper airway in order to keep the airway open during sleep. The implant delivers mild electrical stimulation to the hypoglossal nerve, preventing the tongue from obstructing breathing.